Healthy Extracts director Bill Croyle resigns
Healthy Extracts Inc. disclosed the September 13, 2026 resignation of director Bill Croyle, leaving his board and committee seats vacant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
HEALTHY EXTRACTS INC. (HYEX) reported a corporate governance change: on September 13, 2026, Bill Croyle resigned from the Board of Directors. His board seat and committee positions will remain vacant until further notice, leaving the company with a reduced board presence while it determines future appointments.
Positive
- None.
Negative
- Director resignation and vacant board seat: On September 13, 2026, director Bill Croyle resigned from the Board of Directors, and the company stated his board and committee positions will remain vacant until further notice, creating a period of reduced board representation.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Director resignation date: September 13, 2026
Form type: Form 8-K
Signature date: September 14, 2026
+1 more
4 metrics
Director resignation date
September 13, 2026
Date Bill Croyle resigned from the Board of Directors
Form type
Form 8-K
Used to report the director resignation under Item 5.02
Signature date
September 14, 2026
Date the report was signed by the Chief Executive Officer
Registrant phone number
(702) 463-1004
Telephone number listed for Healthy Extracts Inc.
Key Terms
Emerging growth company, Board of Directors, Exchange Act, Compensatory Arrangements
4 terms
Emerging growth company regulatory
"Emerging growth company Section 5 – Corporate Governance"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Board of Directors regulatory
"Bill Croyle resigned from our Board of Directors."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Exchange Act regulatory
"under the Exchange Act (17 CFR 240.14a-12)"
A federal law that sets rules for trading securities on public exchanges, requiring companies and market participants to register, disclose regular financial information, and follow standards that promote honest, orderly markets. For investors, it matters because it creates transparency and legal protections—like stopping insider trading and ensuring timely company disclosures—so you can evaluate risks and rely on consistent rules much as players rely on a referee to keep a game fair.
Compensatory Arrangements financial
"Appointment of Certain Officers; Compensatory Arrangements of Certain Officers."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did HEALTHY EXTRACTS INC. (HYEX) announce on September 13, 2026?
The company announced that Bill Croyle resigned from its Board of Directors on September 13, 2026. His board and board committee positions will remain vacant until further notice, according to the disclosure.
Does the HYEX filing state who will replace director Bill Croyle?
No successor is named. The filing states that Bill Croyle’s board and committee positions will remain vacant until further notice, indicating the company has not yet filled his roles.
When was the HYEX 8-K regarding the director resignation signed?
The report was signed for Healthy Extracts Inc. on September 14, 2026 by Chief Executive Officer Donald Swanson, one day after the reported resignation date.
Who signed the HYEX 8-K announcing the board resignation?
The 8-K was signed by Donald Swanson, identified as the Chief Executive Officer of Healthy Extracts Inc., on behalf of the registrant.
What SEC form did HYEX use to report the director’s resignation?
Healthy Extracts Inc. reported the resignation on a Form 8-K under Item 5.02, which covers departures of directors or certain officers and related corporate governance matters.
AI-generated analysis. How Rhea-AI works. Not financial advice.
